We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,177.25 +9.75 (+0.19%) Dow Futures
38,299.00 +61.00 (+0.16%) Nasdaq Futures
18,217.50 +38.25 (+0.21%) Russell 2000 Futures
2,028.80 +9.00 (+0.45%) Crude Oil
85.40 -0.26 (-0.30%) Gold
2,369.20 -4.90 (-0.21%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 82.17 |
| Open | 81.74 |
| Bid | 79.75 x 900 |
| Ask | 80.13 x 800 |
| Day's Range | 79.56 - 81.79 |
| 52 Week Range | 68.84 - 92.02 |
| Volume | |
| Avg. Volume | 6,343,095 |
| Market Cap | 106.398B |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | 25.44 |
| EPS (TTM) | 3.15 |
| Earnings Date | May 23, 2024 |
| Forward Dividend & Yield | 2.76 (3.44%) |
| Ex-Dividend Date | Mar 21, 2024 |
| 1y Target Est | 94.18 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for MDT
Related Research
- Medtronic plc.Analyst Report: Medtronic PLCWith operational headquarters in Minnesota, Medtronic is one of the world's largest medical technology and solutions companies. Its devices focus on cardiac rhythm management, spinal and surgical navigation technologies, treatments for diabetes and neurological conditions, vascular therapies, and cardiac surgery. MDT is a component of the S&P 500.RatingFair ValueEconomic Moat3 days agoArgus Research
ZacksMedtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investor's Business DailyWhy Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
Metabolic health is all the rage, helped by the advent of weight-loss drugs and continuous glucose monitors. Can they change disease forever?
ZacksMedtronic's (MDT) Sphere-360 PFA Study Outcome Favorable
Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.
Motley FoolGot $200? 2 Healthcare Stocks to Buy and Hold Forever.
These companies provide stability, reliability, and passive income.
Motley FoolHere Are My Top Artificial Intelligence (AI) Stocks to Buy Now
These three players offer you a great entry point right now.
ZacksMedtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know
Medtronic (MDT) reachead $82.33 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.
MarketWatchThis weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
GLP-1 medications will likely expand beyond their current uses for diabetes or weight loss, according to money managers at Tema
CNW GroupMedtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care.
Simply Wall St.With 85% institutional ownership, Medtronic plc (NYSE:MDT) is a favorite amongst the big guns
Key Insights Institutions' substantial holdings in Medtronic implies that they have significant influence over the...
ACCESSWIRENew Documentary Released by Medtronic: "A Voice for Health"
Join us on a journey to Kenya and discover how Medtronic LABS is expanding access to essential healthcare. NORTHAMPTON, MA / ACCESSWIRE / April 8, 2024 / Yesterday was World Health Day, and the theme this year is ‘My health, my right'. Over half the ...
Morningstar Rating
Rating
Fair Value
Economic Moat
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| ABT Abbott Laboratories | |||
| BSX Boston Scientific Corporation | |||
| SYK Stryker Corporation | |||
| AMGN Amgen Inc. | |||
| BDX Becton, Dickinson and Company |
Similar to MDT
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| ABT Abbott Laboratories | |||
| BSX Boston Scientific Corporation | |||
| SYK Stryker Corporation | |||
| EW Edwards Lifesciences Corporation | |||
| DXCM DexCom, Inc. |
Analyst Price Targets (26)
Upgrades & Downgrades
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 2/21/2024 | |
| Maintains | Oppenheimer: Perform to Perform | 2/21/2024 | |
| Maintains | Mizuho: Buy to Buy | 2/21/2024 | |
| Maintains | Truist Securities: Hold to Hold | 2/21/2024 | |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 1/12/2024 | |
| Maintains | Truist Securities: Hold to Hold | 12/22/2023 |
Company Profile
20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
https://www.medtronic.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 95,000
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
